In the realm of biological research, particularly when working with transgenic models, precise tools are essential. My experience with the OT-II peptide has highlighted its role as a fundamental component for studying T-cell biology. Whether you are mapping epitopes or investigating T-cell activation pathways, understanding the specificity and structural requirements of this peptide is crucial for consistent results.
The Nature of the OT-II Peptide
The OT-II peptide, often referred to by its sequence H-ISQAVHAAHAEINEAGR-OH, is derived from chicken ovalbumin. It is specifically recognized by the T-cell receptor (TCR) found in OT-II transgenic mice. These transgenic mice OVA (329-339) induces to reach the half-maximal proliferationwith 25 μM and 30 μM in DO11.10 and OT-II cell, respectively. MedChemExpress (MCE) has not Read more express the mouse alpha-chain and beta-chain T cell receptor that pairs with the CD4 co-receptor, making them an invaluable model for tracking CD4+ T-cell responses.
From a structural standpoint, the peptide is defined as OVA peptide 323-339. While some protocols utilize the full sequence, others look at shorter variations, suc Angiotensin-converting enzyme affects the presentation of h as OVA (ovalbumin) peptide residues 257 to 280, though the 323-339 fragment is the standard for most OT-II related assays. Researchers often note that the OVA (329-339) induces to reach the half-maximal proliferation in specific cell cultures, demonstrating the sensitivity of the system to sequence length.
Key Characteristics and Experimental Utility
When working with these peptides, I have found th Two standard OVApeptidesfor detection use: H-2Kb-restricted OVA class I epitope and an I-A(d)-restricted OVA classIIepitope. Endotoxin-free. at consistency in preparation is key. The OVA wt peptide 323-339 is frequently used because it is both specific for a C-terminal epitope that resides within the ovalbumin protein. This makes it a highly reliable tool for:
* Mapping T-cell Epitopes: OVA-II is a widely used tool for mapping T cell epitopes, allowing for the clear identification of activation triggers.
* Monitoring Responses: The use of specialized reagents, such as the I-Ab OVA 323-339 Tetramer, can be used to monitor antigen-specific CD4 T cell responses in OT-II mice with high precision.
* Inhibitory Studies: Some studies have shown that specific compounds, such as OvALT-2 suppresses OVA-specific OT-II T cell proliferation in controlled *in vitro* environments, which is useful for baseline validation.
Insights from the OT-II Model
The OT and II designations are central to this research model. Because the mouse expresses a T cell receptor (TCR) specific for the OVA323-339 peptide, it serves as a "gold standard" for observing how cells interact with specific antigens.
In my own observations, the Ovalbumin protein Ova (323-339) is not just a sequence; it is a gateway to understandi OVA Peptide (323-339) ng the mechanics of MHC class II presentation. While the peptide itself is chemically defined—with a molecular weight of 1,773.9 g/mol—its biological behavior is dependent on the purity and the specific experimental context. Whether you are conducting OT II studies in a lab or verifying the OT II Peptide H-ISQAVHAAHAEINEAGR-OH against control samples, the precision of your reagents will dictate the quality of your data.
Final Thoughts on Best Practices
For those new to this area, remember that the OT-II model is highly 27 Jul 2018—These OT-II transgenic miceexpress the mouse alpha-chain and beta-chain T cell receptorthat pairs with the CD4 co-receptor and is specific for chicken Read more sensitive. Ensuring that your peptide is st by AR Abraham·2024—Purpose : Antigen specific T cell trafficking allows targeted delivery of immune modulating cell therapies into sites of ongoing immune dysregulation.Read more ored correctly and handled according to the manufacturer’s protocols is essential for preventing degradation. Always verify the sequence purity, as even minor variations can alter the activation thresholds of the T-cells. By focusing on these technical details, you can ensure that your experiments remain robust, reproducible, and aligned with OT-II TCR transgenic mice fail to produce anti-ovalbumin current standards in the field.